Continuity of Care: Gaps in OUD Treatment During COVID Shutdowns

Visits to the doctor dropped dramatically in the early months of the COVID-19 pandemic. But with an increase in telehealth visits, patients who were already being treated for opioid use disorder (OUD) continued to see doctors and get prescription refills at a relatively stable rate. That’s according to a new study led by Harvard Medical School researchers.

Read the full study published in JAMA.

You May Also Like…


Submit a Comment

Your email address will not be published. Required fields are marked *